Drug Manufacturers - Specialty & Generic | Healthcare
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.
Market Cap
1771856896
Current Price
74.9
52 Week Range
69.0 - 96.0
Previous Close
75.39
Open
75.76
Sector
Healthcare
Address
Bafna Towers, New No. 68 Old No. 299 Thambu Chetty St, Chennai, 600001, India
Phone
+91-44252-67517
Fax
+91-44252-31264
Website
https://www.bafnapharma.com
Day Low
73.2
Day High
75.76
Dividend Yield
PE Ratio
41.84358
Earnings Per Share
1.79
Beta
0.124
EBITDA
111769000
Book Value
35.579
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Bansilal Mahaveer Chand Bafna | Chief Executive Officer | 63 | 1961 |
Mr. Melagiri Sridhar | Chief Financial Officer | 56 | 1968 |
Mr. Vinayak Dinesh Dendukuri | Whole-Time Director of Quality | 37 | 1987 |
Ms. Shanmugam Hemalatha | Executive Chairman | 49 | 1975 |
Mr. A. Mohanachandran | Company Secretary & Compliance Officer | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.